BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15078086)

  • 1. Violaxanthin de-epoxidase, the xanthophyll cycle enzyme, requires lipid inverted hexagonal structures for its activity.
    Latowski D; Akerlund HE; Strzałka K
    Biochemistry; 2004 Apr; 43(15):4417-20. PubMed ID: 15078086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of hexagonal structure-forming lipids in diadinoxanthin and violaxanthin solubilization and de-epoxidation.
    Goss R; Lohr M; Latowski D; Grzyb J; Vieler A; Wilhelm C; Strzalka K
    Biochemistry; 2005 Mar; 44(10):4028-36. PubMed ID: 15751979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of monogalactosyldiacylglycerol and other thylakoid lipids on violaxanthin de-epoxidation in liposomes.
    Latowski D; Kostecka A; Strzałka K
    Biochem Soc Trans; 2000 Dec; 28(6):810-2. PubMed ID: 11171216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of violaxanthin de-epoxidation by violaxanthin de-epoxidase, a xanthophyll cycle enzyme, is regulated by membrane fluidity in model lipid bilayers.
    Latowski D; Kruk J; Burda K; Skrzynecka-Jaskier M; Kostecka-Gugała A; Strzałka K
    Eur J Biochem; 2002 Sep; 269(18):4656-65. PubMed ID: 12230579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid dependence of diadinoxanthin solubilization and de-epoxidation in artificial membrane systems resembling the lipid composition of the natural thylakoid membrane.
    Goss R; Latowski D; Grzyb J; Vieler A; Lohr M; Wilhelm C; Strzalka K
    Biochim Biophys Acta; 2007 Jan; 1768(1):67-75. PubMed ID: 16843433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical model describing kinetics of conversion of violaxanthin to zeaxanthin via intermediate antheraxanthin by the xanthophyll cycle enzyme violaxanthin de-epoxidase.
    Latowski D; Burda K; Strzałka K
    J Theor Biol; 2000 Oct; 206(4):507-14. PubMed ID: 11013111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of violaxanthin de-epoxidation from the stroma and lumen sides of isolated thylakoid membranes from Arabidopsis: implications for the mechanism of de-epoxidation.
    Macko S; Wehner A; Jahns P
    Planta; 2002 Dec; 216(2):309-14. PubMed ID: 12447545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbate deficiency can limit violaxanthin de-epoxidase activity in vivo.
    Müller-Moulé P; Conklin PL; Niyogi KK
    Plant Physiol; 2002 Mar; 128(3):970-7. PubMed ID: 11891252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laurdan fluorescence spectroscopy in the thylakoid bilayer: the effect of violaxanthin to zeaxanthin conversion on the galactolipid dominated lipid environment.
    Szilágyi A; Selstam E; Akerlund HE
    Biochim Biophys Acta; 2008 Jan; 1778(1):348-55. PubMed ID: 17980143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional roles of the major chloroplast lipids in the violaxanthin cycle.
    Yamamoto HY
    Planta; 2006 Aug; 224(3):719-24. PubMed ID: 16532316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of the lipid phase in the dynamics and functions of the xanthophyll cycle as revealed by PsbS overexpression in tobacco and in-vitro de-epoxidation in monogalactosyldiacylglycerol micelles.
    Hieber AD; Kawabata O; Yamamoto HY
    Plant Cell Physiol; 2004 Jan; 45(1):92-102. PubMed ID: 14749490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Violaxanthin and diadinoxanthin de-epoxidation in various model lipid systems.
    Latowski D; Goss R; Bojko M; Strzałka K
    Acta Biochim Pol; 2012; 59(1):101-3. PubMed ID: 22428134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane curvature stress controls the maximal conversion of violaxanthin to zeaxanthin in the violaxanthin cycle--influence of alpha-tocopherol, cetylethers, linolenic acid, and temperature.
    Szilágyi A; Sommarin M; Akerlund HE
    Biochim Biophys Acta; 2007 Sep; 1768(9):2310-8. PubMed ID: 17618598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xanthophyll synthesis in diatoms: quantification of putative intermediates and comparison of pigment conversion kinetics with rate constants derived from a model.
    Lohr M; Wilhelm C
    Planta; 2001 Feb; 212(3):382-91. PubMed ID: 11289603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of phase transitions in phosphatidylethanolamine models on the activity of violaxanthin de-epoxidase.
    Vieler A; Scheidt HA; Schmidt P; Montag C; Nowoisky JF; Lohr M; Wilhelm C; Huster D; Goss R
    Biochim Biophys Acta; 2008 Apr; 1778(4):1027-34. PubMed ID: 18178148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAD is a further essential cofactor of the NAD(P)H and O2-dependent zeaxanthin-epoxidase.
    Büch K; Stransky H; Hager A
    FEBS Lett; 1995 Nov; 376(1-2):45-8. PubMed ID: 8521963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of non-bilayer lipid phases and the structure and functions of thylakoid membranes: effects on the water-soluble enzyme violaxanthin de-epoxidase.
    Dlouhý O; Kurasová I; Karlický V; Javornik U; Šket P; Petrova NZ; Krumova SB; Plavec J; Ughy B; Špunda V; Garab G
    Sci Rep; 2020 Jul; 10(1):11959. PubMed ID: 32686730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the compatible solute sucrose on thylakoid membrane organization and violaxanthin de-epoxidation.
    Goss R; Schwarz C; Matzner M; Wilhelm C
    Planta; 2021 Aug; 254(3):52. PubMed ID: 34392410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of grana stacking for xanthophyll cycle-dependent NPQ in the thylakoid membranes of higher plants.
    Goss R; Oroszi S; Wilhelm C
    Physiol Plant; 2007 Nov; 131(3):496-507. PubMed ID: 18251887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The main thylakoid membrane lipid monogalactosyldiacylglycerol (MGDG) promotes the de-epoxidation of violaxanthin associated with the light-harvesting complex of photosystem II (LHCII).
    Schaller S; Latowski D; Jemioła-Rzemińska M; Wilhelm C; Strzałka K; Goss R
    Biochim Biophys Acta; 2010 Mar; 1797(3):414-24. PubMed ID: 20035710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.